News

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has officially submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) for its MiniMed™ 780G pump and SmartGuard™ algorithm, paving the way for seamless integration with Abbott’s advanced continuous glucose monitoring (CGM) platform. This critical regulatory milestone strengthens Medtronic’s strategic partnership with Abbott and positions the company to deliver more interoperable, intelligent diabetes care solutions to the U.S. market.

Accelerating Innovation Through Strategic Interoperability

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approval for the OmniaSecure™ defibrillation lead—the smallest-diameter, catheter-delivered defibrillation lead for right ventricular implantation. This approval marks a major advancement in cardiac rhythm management, offering physicians a less invasive, highly durable solution to treat life-threatening arrhythmias in both adults and adolescents with smaller anatomies.

Strategic Advancement in Cardiac Rhythm Management

The FDA’s green light for the OmniaSecure lead strengthens Medtronic’s leadership in electrophysiology and expands its robust portfolio of transvenous lead solutions. At only 4.7 French (1.6mm) in diameter, the OmniaSecure lead builds on the proven SelectSecure™ Model 3830 pacing lead platform, already widely adopted in the clinical community for over two decades.

SHERIDAN, WYOMING – May 5, 2025 – Medtronic has announced a major milestone for its Hugo™ robotic-assisted surgery (RAS) system, as the Expand URO U.S. clinical trial met both primary safety and effectiveness endpoints. The results position the company for strategic market entry into the U.S. robotic-assisted surgery sector, the largest of its kind globally, and were presented as a late-breaking session at the American Urologic Association (AUA) annual meeting in Las Vegas.

Landmark Trial Sets New Benchmark in Robotic Urologic Surgery

The Expand URO study is the largest Investigational Device Exemption (IDE) trial conducted in the U.S. for multi-port robotic-assisted urologic procedures. Designed as a prospective, multi-center, single-arm study, it involved 137 patients across six hospitals. Participants underwent one of three common urologic surgeries — prostatectomy, nephrectomy, or cystectomy — using the Hugo RAS system.

SHERIDAN, WYOMING – May 5, 2025 – Medtronic plc (NYSE: MDT) has announced encouraging one-year clinical outcomes for its investigational Affera™ pulsed field ablation (PFA) technologies, reinforcing its strategic leadership in arrhythmia management. The results—revealed at the Heart Rhythm Society 2025 Annual Meeting—highlight the performance of the next-generation Sphere-360™ single-shot PFA catheter and the dual-energy Sphere-9™ catheter in treating patients with paroxysmal and persistent atrial fibrillation (AFib), one of the world’s most prevalent cardiac rhythm disorders.

Sphere-360™ Demonstrates Safety, Efficiency, and Superior Mapping Integration

The Sphere-360 catheter, part of the Affera ecosystem, is engineered as a single-shot PFA mapping and ablation tool designed specifically for paroxysmal AFib. In a European-based, multi-center clinical trial, the technology achieved:

SHERIDAN, WYOMING - May 5, 2025 - In the evolving landscape of restorative dentistry, post-endodontic restoration has emerged as a cornerstone of long-term tooth preservation strategies, offering clinicians and patients alike a pathway to restore function, aesthetics, and durability following root canal therapy. New insights from recent clinical literature highlight the increasing relevance of this specialized restorative approach for practitioners focused on optimizing patient outcomes and return on investment in dental care.

Driving Longevity Through Strategic Restoration

SHERIDAN, WYOMING - May 5, 2025 - In a dental landscape increasingly dominated by minimally invasive approaches, orthognathic surgery-supported by pre- and post-surgical orthodontics-is regaining prominence as a critical solution for addressing complex skeletal deformities that fall beyond the scope of traditional orthodontics.

This resurgent interest is not merely cosmetic. When aesthetic, functional, and long-term stability outcomes are considered, orthognathic surgery emerges as a high-ROI treatment path for select cases. It effectively bridges orthodontic limitations by offering predictable, stable results where skeletal discrepancies compromise both occlusion and facial harmony.

Orthognathic Surgery: A Modern Answer to Structural Challenges

SHERIDAN, WYOMING - May 5, 2025 - The integration of digital technology in dentistry is revolutionizing how dental professionals approach aesthetic treatments, offering enhanced predictability, improved patient engagement, and cross-disciplinary collaboration-while also presenting operational and financial challenges for broader adoption.

Once a futuristic concept, digital dentistry has now become a foundational component in modern dental practices. With advanced software tools like Digital Smile Design (DSD) and the Digital Smile System enabling highly personalized smile simulations, the field is experiencing a strategic shift that enhances both patient outcomes and clinical efficiency.

Transforming Smile Design Through Digital Innovation

SHERIDAN, WYOMING – May 5, 2025 – As dental clinics across the globe continue to strengthen their infection control protocols, the proper use of disinfectants remains a cornerstone of safety. While these products play a pivotal role in preventing cross-infections, recent analyses underscore the need for heightened awareness of the associated chemical and biological risks—making the responsible use of dental disinfectants a strategic imperative for operational safety and compliance.

Balancing Infection Control with Occupational Safety

Cross-infection continues to rank among the most serious complications in healthcare settings, impacting up to 10% of hospitalized patients and generating a staggering annual cost of approximately $4.5 billion in the United States. Though precise figures for dental environments remain difficult to quantify, the threat is real—extending from patients to staff and even external technicians.

SHERIDAN, WYOMING – May 5, 2025 – Ecosite Elements, a leading composite restorative solution, has been prominently featured in the May 2025 issue of Inside Dentistry, spotlighting its clinical effectiveness through a comprehensive case report authored by Dr. Jeff Lineberry. The report highlights a 32-year-old patient presenting with multiple anterior tooth fractures, successfully treated using Ecosite Elements for a highly esthetic and functional outcome.

This feature underscores Ecosite Elements’ growing reputation among dental professionals as a go-to choice for restorative excellence. With a focus on esthetics, efficiency, and material adaptability, the case study demonstrates how modern composite technologies are transforming chairside outcomes and supporting better long-term patient care.

Clinical Precision and Esthetic Performance

SHERIDAN, WYOMING – May 5, 2025 – Dental professionals seeking to enhance their clinical expertise in micro-invasive treatments can now register for a complimentary continuing education (CE) webinar titled “Mastering Resin Infiltration for Predictable Results”, hosted by industry leader Irene Iancu, BSc, RRDH, CTDP, OM. The session, scheduled for June 17, 2025, at 7PM ET, offers one CE credit and delivers a strategic deep dive into the resin infiltration technique using DMG’s Icon system.

Enhancing Practice Outcomes Through Resin Infiltration

Resin infiltration has emerged as a game-changing alternative in the conservative treatment of early carious lesions, providing dentists and hygienists with an advanced, esthetically favorable approach. This CE webinar is designed to help professionals incorporate this micro-invasive procedure into their clinical workflow with confidence and predictability.